Trio booked after cops find hundreds of pot vapes, thousands of dollars ...

Iowa Attorney General Brenna Bird announced a legal victory as the state's lawsuit against Roblox, alleging misleading safety practices, moves forward.

Share on Pinterest Ozempic is now available as a reformulated oral tablet for people with type 2 diabetes. Image courtesy of Novo Nordisk The GLP-1 medication Ozempic is now available in pill form for ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

While GLP-1 weight loss meds have been a mainstay in pop culture for a few years now, they're potentially about to get even more widespread. Formerly only available as an injection, Wegovy recently ...

Viagra can help men rise to the occasion, and so much more. For decades, there seemed to be one straightforward benefit of taking erection pills — an easy way for men to get it up and get it on. But ...

GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...

In 2026, new obesity pills will push the booming GLP-1 market into its next chapter. Pills may serve as a more convenient — and in certain cases cheaper — alternative to today's blockbuster injections ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection. Patients with a prescription could obtain the starter 1.5 mg dose of the tablet ...

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The ...

Matt Fuchs writes about science, health, aging, and well-being. His Substack is Prime Factors and he is a 2026-2027 Knight-Wallace Fellow. Matt Fuchs writes about science, health, aging, and ...